Advances in the Treatment of Non–Small Cell Lung Cancer
Author:
Funder
AstraZeneca
Celgene
Pfizer
Novartis
Merck
Amgen
Carefusion
G1 therapeutics
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine
Reference73 articles.
1. Allele-specific HLA loss and immune escape in lung cancer evolution;McGranahan;Cell,2017
2. Neoantigen-directed immune escape in lung cancer evolution;Rosenthal;Nature,2019
3. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses;Lavin;Cell,2017
4. Immune evasion before tumour invasion in early lung squamous carcinogenesis;Mascaux;Nature,2019
5. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation;Krummel;J Exp Med,1995
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Social and Biological Determinants in Lung Cancer Disparity;Cancers;2024-01-31
2. APOC1 reduced anti-PD-1 immunotherapy of nonsmall cell lung cancer via the transformation of M2 into M1 macrophages by ferroptosis by NRF2/HO-1;Anti-Cancer Drugs;2024-01-22
3. Tumor mutational burden as a predictive biomarker for non-small cell lung cancer treated with immune checkpoint inhibitors of PD-1/PD-L1;Clinical and Translational Oncology;2024-01-08
4. Progress in Immunotherapy of Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024
5. The clinical application of immuno-therapeutics;Clinical Immuno-Oncology;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3